13F

Stock

IGC Pharma, Inc.

IGC · held by 35 managers

Reported value

$1.13M

Holders

35

+7 new · −4 exited

Holders’ est. mark

−$53.3K

Price effect on 24 books still in the name

Largest holder

$274.4K

GEODE CAPITAL MANAGEMENT, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
GEODE CAPITAL MANAGEMENT, LLC1.04M$274.4K−$15.8KAdded$32.3K
VANGUARD CAPITAL MANAGEMENT LLC718.4K$188.9KHeld
BlackRock, Inc.703.8K$185.1K−$13KCut−$12.9K
Renaissance Technologies484K$127.3K−$8.91KCut−$131.5K
VANGUARD FIDUCIARY TRUST CO415.9K$109.4KHeld
State Street200.8K$52.8K−$3.69KCut−$3.69K
SUSQUEHANNA INTERNATIONAL GROUP, LLP122.6K$32.2K−$2.26KCut−$11.4K
NORTHERN TRUST CORP113.4K$29.8K−$2.09KCut−$2.09K
LAWOOD & CO75K$19.7K−$1.38KCut−$1.38K
GOLDMAN SACHS GROUP INC65.5K$17.2K−$1.21KCut−$1.21K
DEARBORN PARTNERS LLC59.4K$15.6K−$1.09KCut−$8.13K
XTX Topco Ltd50.6K$13.3K−$521Added$5.35K
Fisher Asset Management, LLC43.4K$11.4K−$798Cut−$798
TRUIST FINANCIAL CORP36.7K$9.64K−$675Cut−$675
MORGAN STANLEY35.1K$9.24K−$326Added$4.25K
COMMONWEALTH EQUITY SERVICES, LLC33.8K$8.9K−$611Cut−$480
Tower Research Capital LLC (TRC)21K$5.54K−$265Added$1.49K
T3 Companies, LLC20K$5.26K−$368Cut−$368
Vanguard Global Advisers, LLC14.9K$3.93KHeld
Schneider Downs Wealth Management Advisors, LP10K$2.63KNew
Wealthcare Advisory Partners LLC10K$2.63KNew
HighTower Advisors, LLC10K$2.63KNew
UBS Group AG8.1K$2.13K−$146Cut−$3.45K
Trask Adam Roland5K$1.31KHeld
GROUP ONE TRADING LLC3.76K$989−$69Cut−$1.03K
Geneos Wealth Management Inc.3K$780−$60Cut−$60
CWM, LLC1K$263New
Caitlin John, LLC200$53−$3Cut−$3
Farther Finance Advisors, LLC101$27−$1Cut−$1
Hurley Capital, LLC100$26−$2Cut−$2
DHJJ Financial Advisors, Ltd.80$22−$1Cut−$1
Napier Financial, LLC58$15New
Virtu Financial LLC23.2K$6New
Triumph Capital Management2$1$0Held
Johnson Financial Group, Inc.1$1New

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.